VEGF-A and VEGF-F evoke distinct changes in vascular ultrastructure

Biochemical and Biophysical Research Communications

Volumn 379, Issue 4, 2009, Pages 872-875

  Matsunaga, Yukiko ^a   Yamazaki, Yasuo ^a   Suzuki, Hidenori ^b   Morita, Takashi ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Fenestrae; Snake venom; Transmission electron microscopy; Vammin; Vascular endothelial growth factor; Vascular permeability; Vesiculo vacuolar organelle; VVO

Indexed keywords

UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR F; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; STIMULATION; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ANIMALS; CAPILLARIES; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; GUINEA PIGS; MICROSCOPY, ELECTRON, TRANSMISSION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIPER VENOMS;

EID: 58949093380     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.129     Document Type: Article

References (28)

1. Weis S.M., and Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437 (2005) 497-504
2. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., and Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (1983) 983-985
3. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell. Biol. 7 (2006) 359-371
4. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
5. Meyer M., Clauss M., Lepple-Wienhues A., Waltenberger J., Augustin H.G., Ziche M., Lanz C., Buttner M., Rziha H.J., and Dehio C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 18 (1999) 363-374
6. Yamazaki Y., and Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol. Divers 10 (2006) 515-527
7. Yamazaki Y., Takani K., Atoda H., and Morita T. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J. Biol. Chem. 278 (2003) 51985-51988
8. Yamazaki Y., Nakano Y., Imamura T., and Morita T. Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem. Biophys. Res. Commun. 355 (2007) 693-699
9. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269 (1994) 25646-25654
10. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., Saksela O., Kalkkinen N., and Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16 (1997) 3898-3911
11. Ogawa S., Oku A., Sawano A., Yamaguchi S., Yazaki Y., and Shibuya M. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 273 (1998) 31273-31282
12. Wise L.M., Veikkola T., Mercer A.A., Savory L.J., Fleming S.B., Caesar C., Vitali A., Makinen T., Alitalo K., and Stacker S.A. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc. Natl. Acad. Sci. USA 96 (1999) 3071-3076
13. Louzier V., Raffestin B., Leroux A., Branellec D., Caillaud J.M., Levame M., Eddahibi S., and Adnot S. Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 284 (2003) L926-L937
14. Stacker S.A., Vitali A., Caesar C., Domagala T., Groenen L.C., Nice E., Achen M.G., and Wilks A.F. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability. J. Biol. Chem. 274 (1999) 34884-34892
15. Feng D., Nagy J.A., Pyne K., Hammel I., Dvorak H.F., and Dvorak A.M. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 6 (1999) 23-44
16. Dvorak H.F., Nagy J.A., Feng D., Brown L.F., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237 (1999) 97-132
17. Nagy J.A., Benjamin L., Zeng H., Dvorak A.M., and Dvorak H.F. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11 (2008) 109-119
18. Nagy J.A., Masse E.M., Herzberg K.T., Meyers M.S., Yeo K.T., Yeo T.K., Sioussat T.M., and Dvorak H.F. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res. 55 (1995) 360-368
19. Feng D., Nagy J.A., Dvorak A.M., and Dvorak H.F. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc. Res. 59 (2000) 24-37
20. Roberts W.G., and Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108 Pt 6 (1995) 2369-2379
21. Nedospasov A., Rafikov R., Beda N., and Nudler E. An autocatalytic mechanism of protein nitrosylation. Proc. Natl. Acad. Sci. USA 97 (2000) 13543-13548
22. Rafikova O., Rafikov R., and Nudler E. Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control. Proc. Natl. Acad. Sci. USA 99 (2002) 5913-5918
23. Predescu D., Predescu S., and Malik A.B. Transport of nitrated albumin across continuous vascular endothelium. Proc. Natl. Acad. Sci. USA 99 (2002) 13932-13937
24. Beckman J.S., Chen J., Ischiropoulos H., and Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233 (1994) 229-240
25. Fukumura D., Gohongi T., Kadambi A., Izumi Y., Ang J., Yun C.O., Buerk D.G., Huang P.L., and Jain R.K. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. USA 98 (2001) 2604-2609
26. Odorisio T., Schietroma C., Zaccaria M.L., Cianfarani F., Tiveron C., Tatangelo L., Failla C.M., and Zambruno G. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J. Cell Sci. 115 (2002) 2559-2567
27. Luttun A., Brusselmans K., Fukao H., Tjwa M., Ueshima S., Herbert J.M., Matsuo O., Collen D., Carmeliet P., and Moons L. Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem. Biophys. Res. Commun. 295 (2002) 428-434
28. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., DiPalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D., and Persico M.G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7 (2001) 575-583